Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial
Lucia, M. Scott, Epstein, Jonathan I., Goodman, Phyllis J., Darke, Amy K., Reuter, Victor E., Civantos, Francisco, Tangen, Catherine M., Parnes, Howard L., Lippman, Scott M., La Rosa, Francisco G., Kattan, Michael W., Crawford, E. David, Ford, Leslie G., Coltman, Charles A., Thompson, Ian M.
Published in JNCI : Journal of the National Cancer Institute (19.09.2007)
Published in JNCI : Journal of the National Cancer Institute (19.09.2007)
Get full text
Journal Article
Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer
Umbehr, M H, Gurel, B, Murtola, T J, Sutcliffe, S, Peskoe, S B, Tangen, C M, Goodman, P J, Thompson, I M, Lippman, S M, Lucia, M S, Parnes, H L, Drake, C G, Nelson, W G, De Marzo, A M, Platz, E A
Published in Prostate cancer and prostatic diseases (01.09.2015)
Published in Prostate cancer and prostatic diseases (01.09.2015)
Get full text
Journal Article
Phase III Study of Cyclophosphamide, Doxorubicin, and Fluorouracil (CAF) Plus Leucovorin Versus CAF for Metastatic Breast Cancer: Cancer and Leukemia Group B 9140
PARNES, H. L, CIRRINCIONE, C, SZATROWSKI, T. P, HENDERSON, I. C, NORTON, L, AISNER, J, BERRY, D. A, ALLEN, S. L, ABRAMS, J, CHUANG, E, COOPER, M. R, PERRY, M. C, DUGGAN, D. B
Published in Journal of clinical oncology (01.05.2003)
Published in Journal of clinical oncology (01.05.2003)
Get full text
Journal Article
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
Thompson, Ian M, Pauler, Donna K, Goodman, Phyllis J, Tangen, Catherine M, Lucia, M. Scott, Parnes, Howard L, Minasian, Lori M, Ford, Leslie G, Lippman, Scott M, Crawford, E. David, Crowley, John J, Coltman, Charles A
Published in The New England journal of medicine (27.05.2004)
Published in The New England journal of medicine (27.05.2004)
Get full text
Journal Article
Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
Taylor, Philip R., Parnes, Howard L., Lippman, Scott M.
Published in JNCI : Journal of the National Cancer Institute (05.05.2004)
Published in JNCI : Journal of the National Cancer Institute (05.05.2004)
Get full text
Journal Article
A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer
Parnes, H L, Abrams, J S, Tchekmedyian, N S, Tait, N, Aisner, J
Published in Breast cancer research and treatment (01.08.1991)
Published in Breast cancer research and treatment (01.08.1991)
Get more information
Journal Article
A phase I study of cabozantinib plus nivolumab (CaboNivo) in patients (pts) refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors
Apolo, A.B., Mortazavi, A., Stein, M., Pal, S.K., Davarpanah, N., Parnes, H.L., Ning, Y.M., Francis, D.C., Cordes, L.M., Berniger, M., Steinberg, S.M., Monk, P., Lancaster, T., Mayer, T., Costello, R., Bottaro, D.P., Dahut, W.L.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
A phase II study of cabozantinib in patients (pts) with relapsed/refractory metastatic urothelial carcinoma (mUC)
Nadal, R., Parnes, H.L., Francis, D.C., Cordes, L.M., Berninger, M., Costello, R., Folio, L., Linderberg, M., Machado, L., Steinberg, S.M., Wright, J.J., Ning, Y.M., Bottaro, D.P., Dahut, W.L., Apolo, A.B.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, Ian M., Ankerst, Donna Pauler, Chi, Chen, Goodman, Phyllis J., Tangen, Catherine M., Lucia, M. Scott, Feng, Ziding, Parnes, Howard L., Coltman, Charles A.
Published in JNCI : Journal of the National Cancer Institute (19.04.2006)
Published in JNCI : Journal of the National Cancer Institute (19.04.2006)
Get full text
Journal Article
Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower
Thompson, Ian M, Ankerst, Donna Pauler, Chi, Chen, Lucia, M. Scott, Goodman, Phyllis J, Crowley, John J, Parnes, Howard L, Coltman, Charles A
Published in JAMA : the journal of the American Medical Association (06.07.2005)
Published in JAMA : the journal of the American Medical Association (06.07.2005)
Get full text
Journal Article
Intraprostatic inflammation is positively associated with serum PSA in men with PSA [less-than] 4 ng ml^sup -1^, normal DRE and negative for prostate cancer
Umbehr, M H, Gurel, B, Murtola, T J, Sutcliffe, S, Peskoe, S B, Tangen, C M, Goodman, P J, Thompson, I M, Lippman, S M, Lucia, M S, Parnes, H L, Drake, C G, Nelson, W G, De Marzo, A M, Platz, E A
Published in Prostate cancer and prostatic diseases (01.09.2015)
Published in Prostate cancer and prostatic diseases (01.09.2015)
Get full text
Journal Article
Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml−1, normal DRE and negative for prostate cancer
Umbehr, M H, Gurel, B, Murtola, T J, Sutcliffe, S, Peskoe, S B, Tangen, C M, Goodman, P J, Thompson, I M, Lippman, S M, Lucia, M S, Parnes, H L, Drake, C G, Nelson, W G, De Marzo, A M, Platz, E A
Published in Prostate cancer and prostatic diseases (05.05.2015)
Published in Prostate cancer and prostatic diseases (05.05.2015)
Get full text
Journal Article
Phase II trial of bevacizumab (A), lenalidomide (R), docetaxel (D), and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Huang, X., Ning, Y. M., Mulquin, M., Madan, R. A., Gulley, J. L., Kluetz, P. G., Adelberg, D., Arlen, P. M., Parnes, H. L., Adesunloye, B., Steinberg, S. M., Wright, J. J., Trepel, J. B., Chen, C., Bassim, C., Apolo, A. B., Figg, W. D., Dahut, W. L.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial
Baker, Stuart G, Darke, Amy K, Pinsky, Paul, Parnes, Howard L, Kramer, Barnett S
Published in Biostatistics (Oxford, England) (01.07.2010)
Published in Biostatistics (Oxford, England) (01.07.2010)
Get full text
Journal Article
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Lippman, Scott M., Goodman, Phyllis J., Klein, Eric A., Parnes, Howard L., Thompson, Ian M., Kristal, Alan R., Santella, Regina M., Probstfield, Jeffrey L., Moinpour, Carol M., Albanes, Demetrius, Taylor, Philip R., Minasian, Lori M., Hoque, Ashraful, Thomas, Sarah Moody, Crowley, John J., Gaziano, J. Michael, Stanford, Janet L., Cook, Elise D., Fleshner, Neil E., Lieber, Michael M., Walther, Philip J., Khuri, Fadlo R., Karp, Daniel D., Schwartz, Gary G., Ford, Leslie G., Coltman, Charles A.
Published in JNCI : Journal of the National Cancer Institute (19.01.2005)
Published in JNCI : Journal of the National Cancer Institute (19.01.2005)
Get full text
Journal Article
Phase II clinical trial of cediranib in patients with metastatic castration‐resistant prostate cancer
Dahut, William L., Madan, Ravi A., Karakunnel, Joyson J., Adelberg, David, Gulley, James L., Turkbey, Ismail B., Chau, Cindy H., Spencer, Shawn D., Mulquin, Marcia, Wright, John, Parnes, Howard L., Steinberg, Seth M., Choyke, Peter L., Figg, William D.
Published in BJU international (01.06.2013)
Published in BJU international (01.06.2013)
Get full text
Journal Article